483
Pharmalogic Los Angeles, LLCPharmalogic Los Angeles, LLC – FDA 483, Feb 5, 2026
Record Details
An FDA inspection of PharmaLogic Los Angeles, LLC, a manufacturer of PET drugs, revealed a significant deficiency in their quality system. The firm failed to approve or reject processes and procedures before implementation, specifically regarding the visual inspection of PET drug products. This issue raises concerns about the adequacy of operator training and the ability to detect defects, potentially impacting drug identity, strength, quality, and purity.
View Company Profile
ID · f616832d-321c-4b48-9c6a-176290745154
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.